Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Bloomberg Customers


February 10, 2016 8:46 AM ET

Healthcare Equipment and Supplies

Company Overview of Roka Bioscience, Inc.

Company Overview

Roka Bioscience, Inc., a molecular diagnostics company, focuses on the development and commercialization of molecular assay technologies for the detection of foodborne pathogens in the United States. It provides Atlas instrument, a fully automated molecular diagnostic testing instrument to reduce labor costs and operator error in high-volume foodborne pathogen testing laboratories. The company also offers atlas detection assays that include molecular tests for Salmonella, Listeria, E. coli O157:H7, Shiga toxin- producing E.coli, and Listeria monocytogenes, as well as related consumable supplies. It serves food processors, third-party contract testing laboratories, and government regulatory a...

20 Independence Boulevard

4th Floor

Warren, NJ 07059

United States

Founded in 2009

110 Employees

Phone:

908-605-4700

Key Executives for Roka Bioscience, Inc.

Founder, Chief Executive Officer, President and Director
Age: 59
Total Annual Compensation: $583.6K
Senior Advisor
Age: 58
Total Annual Compensation: $371.6K
Compensation as of Fiscal Year 2014.

Roka Bioscience, Inc. Key Developments

Roka Bioscience, Inc. Reports Unaudited Earnings Results for the Third Quarter and Nine Months Ended September 30, 2015

Roka Bioscience, Inc. reported unaudited earnings results for the third quarter and nine months ended September 30, 2015. For the quarter, the company reported revenue of $1,508,000 against $1,483,000 a year ago. Loss from operations was $8,083,000 against $8,373,000 a year ago. Loss before income taxes was $8,487,000 against $9,072,000 a year ago. Net loss and comprehensive loss was $8,491,000 against $9,083,000 a year ago. Basic and diluted net loss per share was $0.49 against $0.64 a year ago. The increase in third quarter revenue year-on-year resulted from an increase in the number of Atlas(R) instruments placed with commercial customers and increased commercial utilization of the instruments. For the nine months, the company reported revenue of $4,484,000 against $3,701,000 a year ago. Loss from operations was $24,994,000 against $22,742,000 a year ago. Loss before income taxes was $26,582,000 against $24,771,000 a year ago. Net loss and comprehensive loss was $26,592,000 against $24,799,000 a year ago. Basic and diluted net loss per share was $1.54 against $4.78 a year ago.

Roka Bioscience, Inc. Appoints Lars Boesgaard as Vice President and Chief Financial Officer to Replace Steven Sobieski

Roka Bioscience, Inc. announced the appointment of Lars Boesgaard as Vice President and Chief Financial Officer. Mr. Boesgaard, who joined Roka in 2009 and currently serves as Vice President, Finance and Controller, succeeds Steven Sobieski. Mr. Sobieski will continue his association with the company as a Senior Advisor. Mr. Boesgaard has 20 years of finance and accounting experience. He joined Roka in October 2009 as Controller and was promoted to Vice President, Finance in January 2012.

Roka Bioscience, Inc. to Report Q3, 2015 Results on Nov 11, 2015

Roka Bioscience, Inc. announced that they will report Q3, 2015 results at 5:00 PM, Eastern Standard Time on Nov 11, 2015

Similar Private Companies By Industry

Company Name Region
Optical Dynamics Corporation United States
Cellvizio, Inc. United States
OptiMedical Inc. United States
Emergent Detection, Inc. United States
Tenacore Holdings Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Roka Bioscience, Inc., please visit www.rokabio.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.